Home

PharmaCyte Biotech, Inc.

CIK 1157075 · last filed 2025-11-18

PharmaCyte Biotech, Inc. is a corporate insider who has filed 1 SEC Form 4 insider transactions across 1 company since 2025. The most recent filing, for QCLS, was dated Nov 18, 2025. The firm reports its address in Las Vegas, NV. 11 SEC filings were submitted jointly with Iroquois Capital Management, LLC.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$0

Companies

1

Total Filings

1

Lifetime Open-Market Net

$0

Filer Profile

Reported Address
3960 HOWARD HUGHES PARKWAY
SUITE 500
LAS VEGAS, NV 89169
Phone
(917) 595-2850
State of Incorporation
NV
Formerly Known As
NUVILEX, INC. (2009–2015)
EFOODSAFETY COM INC (2001–2009)
Related Filers
Iroquois Capital Management, LLC — 11 joint filings, latest 2023-06-16
JONATHAN SCHECHTER — 7 joint filings, latest 2026-07-17
Michael M Abecassis — 6 joint filings, latest 2026-07-17
WAYNE REMELL WALKER — 6 joint filings, latest 2026-07-17
ROBERT WEINSTEIN — 6 joint filings, latest 2026-07-17
Joshua Silverman — 4 joint filings, latest 2026-01-07
SABBY MANAGEMENT, LLC — 3 joint filings, latest 2023-01-10
Daniel Allen — 2 joint filings, latest 2022-12-30
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
QCLS 10%+ Owner — $0.87 — $0 1 2025-11-18

Recent Filings

1 filing
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2025-11-18 QCLS Buy (P) — $0 EDGAR
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.